356 related articles for article (PubMed ID: 11698484)
41. Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
Zhang J; Gao JX; Salojin K; Shao Q; Grattan M; Meagher C; Laird DW; Delovitch TL
J Exp Med; 2000 Mar; 191(6):1017-30. PubMed ID: 10727463
[TBL] [Abstract][Full Text] [Related]
42. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells.
Fields ML; Sokol CL; Eaton-Bassiri A; Seo S; Madaio MP; Erikson J
J Immunol; 2001 Aug; 167(4):2370-8. PubMed ID: 11490027
[TBL] [Abstract][Full Text] [Related]
43. Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome.
Hayashi Y; Yayagi K; Haneji N
Arch Immunol Ther Exp (Warsz); 2000; 48(5):399-403. PubMed ID: 11140467
[TBL] [Abstract][Full Text] [Related]
44. Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjögren's syndrome.
Ainola M; Porola P; Takakubo Y; Przybyla B; Kouri VP; Tolvanen TA; Hänninen A; Nordström DC
Clin Exp Immunol; 2018 Mar; 191(3):301-310. PubMed ID: 29105068
[TBL] [Abstract][Full Text] [Related]
45. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand.
Huber S; Shi C; Budd RC
J Virol; 2002 Jul; 76(13):6487-94. PubMed ID: 12050361
[TBL] [Abstract][Full Text] [Related]
46. Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3.
Seko Y; Kayagaki N; Seino K; Yagita H; Okumura K; Nagai R
J Am Coll Cardiol; 2002 Apr; 39(8):1399-403. PubMed ID: 11955862
[TBL] [Abstract][Full Text] [Related]
47. [Study of apoptosis in Sjögren's syndrome].
Ogawa N; Ohashi H
Rinsho Byori; 1997 Jul; 45(7):643-8. PubMed ID: 9256010
[TBL] [Abstract][Full Text] [Related]
48. Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver.
Watanabe T; Yoshida M; Shirai Y; Yamori M; Yagita H; Itoh T; Chiba T; Kita T; Wakatsuki Y
J Immunol; 2002 Mar; 168(5):2188-99. PubMed ID: 11859105
[TBL] [Abstract][Full Text] [Related]
49. Fas and Fas-mediated effects on a human salivary cell line in vitro: a model for immune-mediated exocrine damage in Sjögren's syndrome.
Gannot G; Bermudez D; Lillibridge D; Fox PC
Cell Death Differ; 1998 Sep; 5(9):743-50. PubMed ID: 10200533
[TBL] [Abstract][Full Text] [Related]
50. The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.
Priceputu E; Rodrigue I; Chrobak P; Poudrier J; Mak TW; Hanna Z; Hu C; Kay DG; Jolicoeur P
J Virol; 2005 May; 79(10):6377-91. PubMed ID: 15858021
[TBL] [Abstract][Full Text] [Related]
51. Apoptosis and estrogen deficiency in primary Sjögren syndrome.
Hayashi Y; Arakaki R; Ishimaru N
Curr Opin Rheumatol; 2004 Sep; 16(5):522-6. PubMed ID: 15314488
[TBL] [Abstract][Full Text] [Related]
52. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
[TBL] [Abstract][Full Text] [Related]
53. Involvement of Fas/Fas ligand in the induction of apoptosis in chronic sialadenitis of minor salivary glands including Sjögren's syndrome.
Shibata Y; Hishikawa Y; Izumi S; Fujita S; Yamaguchi A; Koji T
Hum Cell; 2002 Mar; 15(1):52-60. PubMed ID: 12126064
[TBL] [Abstract][Full Text] [Related]
54. Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression.
Kaser A; Nagata S; Tilg H
Cytokine; 1999 Oct; 11(10):736-43. PubMed ID: 10525311
[TBL] [Abstract][Full Text] [Related]
55. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype.
Oberg HH; Lengl-Janssen B; Kabelitz D; Janssen O
Cell Immunol; 1997 Oct; 181(1):93-100. PubMed ID: 9344501
[TBL] [Abstract][Full Text] [Related]
56. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome.
Zeher M; Szodoray P; Gyimesi E; Szondy Z
Arthritis Rheum; 1999 Aug; 42(8):1673-81. PubMed ID: 10446867
[TBL] [Abstract][Full Text] [Related]
57. Apoptosis and Sjögren syndrome.
Manganelli P; Fietta P
Semin Arthritis Rheum; 2003 Aug; 33(1):49-65. PubMed ID: 12920696
[TBL] [Abstract][Full Text] [Related]
58. Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.
Kramer JM; Holodick NE; Vizconde TC; Raman I; Yan M; Li QZ; Gaile DP; Rothstein TL
J Leukoc Biol; 2016 Feb; 99(2):321-31. PubMed ID: 26382297
[TBL] [Abstract][Full Text] [Related]
59. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
[TBL] [Abstract][Full Text] [Related]
60. Increased inducible apoptosis in CD4+ T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin.
Ayala A; Chung CS; Xu YX; Evans TA; Redmond KM; Chaudry IH
Immunology; 1999 May; 97(1):45-55. PubMed ID: 10447713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]